These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3916617)

  • 21. Degenerative neuropathy in insulin-treated diabetic rats.
    Westfall SG; Felten DL; Mandelbaum JA; Moore SA; Peterson RG
    J Neurol Sci; 1983 Sep; 61(1):93-107. PubMed ID: 6355399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats.
    Sameni HR; Panahi M; Sarkaki A; Saki GH; Makvandi M
    Pak J Biol Sci; 2008 Aug; 11(16):1994-2000. PubMed ID: 19266905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near nerve local insulin prevents conduction slowing in experimental diabetes.
    Singhal A; Cheng C; Sun H; Zochodne DW
    Brain Res; 1997 Jul; 763(2):209-14. PubMed ID: 9296561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of continuous subcutaneous insulin infusion on renal morphology in experimental diabetes. I. Blood glucose levels, body size, kidney weight and glomerulotubular morphometry.
    Mayhew TM; Sharma AK; McCallum KN
    J Pathol; 1987 Feb; 151(2):147-55. PubMed ID: 3572611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.
    Liu WJ; Jin HY; Lee KA; Xie SH; Baek HS; Park TS
    Br J Pharmacol; 2011 Nov; 164(5):1410-20. PubMed ID: 21323903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phrenic nerve diabetic neuropathy in rats: unmyelinated fibers morphometry.
    Fazan VP; Rodrigues Filho OA; Jordão CE; Moore KC
    J Peripher Nerv Syst; 2009 Jun; 14(2):137-45. PubMed ID: 19691536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.
    Baum P; Koj S; Klöting N; Blüher M; Classen J; Paeschke S; Gericke M; Toyka KV; Nowicki M; Kosacka J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats.
    Jakobsen J
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):509-18. PubMed ID: 469558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 1. Normal animals.
    Fraher JP; O'Leary D; Moran MA; Cole M; King RH; Thomas PK
    Acta Neuropathol; 1990; 79(4):364-74. PubMed ID: 2339590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves.
    Jakobsen J
    Diabetologia; 1976 Dec; 12(6):539-46. PubMed ID: 137157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord.
    Unger JW; Klitzsch T; Pera S; Reiter R
    Exp Neurol; 1998 Sep; 153(1):23-34. PubMed ID: 9743564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats.
    Jamali R; Mohseni S
    Acta Neuropathol; 2005 Feb; 109(2):198-206. PubMed ID: 15549329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonopathy and microangiopathy in chronic alloxan diabetes.
    Powell HC; Myers RR
    Acta Neuropathol; 1984; 65(2):128-37. PubMed ID: 6098120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy in the spontaneously diabetic BB-Wistar-rat. An ultrastructural study.
    Sima AA
    Acta Neuropathol; 1980; 51(3):223-7. PubMed ID: 7445976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
    Sarangarajan R; Cacini W
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve.
    Sugimura K; Windebank AJ; Natarajan V; Lambert EH; Schmid HH; Dyck PJ
    J Neuropathol Exp Neurol; 1980 Nov; 39(6):710-21. PubMed ID: 6450274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
    Lee KA; Lee NY; Park TS; Jin HY
    Endocrine; 2018 Jul; 61(1):58-67. PubMed ID: 29736880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models.
    Stevens EJ; Carrington AL; Tomlinson DR
    Diabetologia; 1994 Jan; 37(1):43-8. PubMed ID: 8150229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.